Leonteq Securities AG’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $57.6K | Sell |
|
|||||
|
2025
Q3 | $67.4K | Sell |
|
|||||
|
2025
Q2 | $133K | Sell |
|
|||||
|
2025
Q1 | $138K | Buy |
|
|||||
|
2024
Q4 | $115K | Buy |
|
|||||
|
2024
Q3 | $60.4K | Buy |
|
|||||
|
2024
Q2 | $30.8K | Buy |
|
|||||
|
2024
Q1 | $27.3K | Buy |
|
|||||
|
2023
Q4 | $7.51K | Sell |
|
|||||
|
2023
Q3 | $23.7K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $62.7K | Hold |
|
|||||
|
2022
Q4 | $73.9K | Sell |
|
|||||
|
2022
Q3 | $213K | Sell |
|
|||||
|
2022
Q2 | $234K | Buy |
|
|||||
|
2022
Q1 | $93.8K | Sell |
|
|||||
|
2021
Q4 | $213K | Sell |
|
|||||
|
2021
Q3 | $254K | Buy |
|
|||||
|
2021
Q2 | $243K | Sell |
|
|||||
|
2021
Q1 | $537K | Buy |
|
|||||
|
2020
Q4 | $376K | Buy |
|